Zobrazeno 1 - 10
of 43
pro vyhledávání: '"UFH, Unfractionated heparin"'
Autor:
Thomas Lecompte, Geoffrey Horlait, Hugues Jacqmin, Silvy Laporte, A. Dive, Isabelle Michaux, Jean-Michel Dogné, Sophie Testa, Céline Chapelle, Michael Hardy, François Mullier, Pierre Bulpa, Jonathan Douxfils, Marion Bareille, Sarah Lessire
Publikováno v:
Thrombosis research, Vol. 197, p. 20-23 (2021)
Hardy, M, Michaux, I, Lessire, S, Douxfils, J, Dogné, J-M, Bareille, M, Horlait, G, Bulpa, P, Chapelle, C, Laporte, S, Testa, S, Jacqmin, H, Lecompte, T, Dive, A & Mullier, F 2021, ' Prothrombotic disturbances of hemostasis of patients with severe COVID-19 : A prospective longitudinal observational study ', Thrombosis Research, vol. 197, pp. 20-23 . https://doi.org/10.1016/j.thromres.2020.10.025
Thrombosis research, Vol. 197, p. 20-23 (2020)
Thrombosis Research
Hardy, M, Michaux, I, Lessire, S, Douxfils, J, Dogné, J-M, Bareille, M, Horlait, G, Bulpa, P, Chapelle, C, Laporte, S, Testa, S, Jacqmin, H, Lecompte, T, Dive, A & Mullier, F 2021, ' Prothrombotic disturbances of hemostasis of patients with severe COVID-19 : A prospective longitudinal observational study ', Thrombosis Research, vol. 197, pp. 20-23 . https://doi.org/10.1016/j.thromres.2020.10.025
Thrombosis research, Vol. 197, p. 20-23 (2020)
Thrombosis Research
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 72, Iss 6, Pp 508-516 (2020)
Indian Heart Journal, Vol 72, Iss 6, Pp 508-516 (2020)
Large intracoronary thrombus has been reported in significant number of patients with STEMI. Primary PCI is the current standard of care in patients of STEMI. Despite the availability of dual antiplatelets, GP IIb/IIIa inhibitor and effective anticoa
Autor:
Hugo Rodríguez-Zanella, Claudia Lerma, Sergio Mora-Canela, Victor Manuel Anguiano-Álvarez, Raúl Izaguirre-Ávila, Gustavo Rojas-Velasco, Flavio A Grimaldo-Gómez, Samuel Ramirez-Marroquin, Ángel Ramos-Enríquez, Adriana Torres-Machorro, Edgar García-Cruz, Evelyn Cortina-de la Rosa
Publikováno v:
Thrombosis Research
Highlights • Clinical signs are not useful for detecting DVT in critically ill COVID-19 patients • DVT occurs despite full dose anticoagulation in critically ill COVID-19 patients • Severe COVID-19 patients present a high prevalence of bilatera
Publikováno v:
JACC: Case Reports, Vol 2, Iss 9, Pp 1383-1387 (2020)
JACC: Case Reports
Jacc. Case Reports
JACC: Case Reports
Jacc. Case Reports
Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. SARS-COV2, a novel coronavirus that causes COVID-19, has been associated with increased risk of thrombosis. We describe the therapeutic ch
Autor:
Andrew P, Cap
Publikováno v:
Chest
Background Pulmonary vascular microthrombi are a proposed mechanism of COVID19 respiratory failure. We hypothesized that early administration of tissue-plasminogen activator(tPA) followed by therapeutic heparin would improve pulmonary function in the
Autor:
Ulbricht, David, Pippel, Jan, Schultz, Stephan, Meier, René, Sträter, Norbert, Heiker, John T.
SerpinA12 (vaspin) is thought to be mainly expressed in adipose tissue and has multiple beneficial effects on metabolic, inflammatory and atherogenic processes related to obesity. KLK7 (kallikrein 7) is the only known protease target of vaspin to dat
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A33439
https://ul.qucosa.de/api/qucosa%3A33439/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A33439/attachment/ATT-0/
Autor:
Andrew S. Herbert, Jawed Fareed, John M. Dye, Samantha E. Zak, Dawid Maciorowski, Yash Gupta, Prakasha Kempaiah, Chandrashekhar Vishwanath Kulkarni, Ravi Durvasula
Publikováno v:
International Journal of Biological Macromolecules
The world is currently facing a novel coronavirus (SARS-CoV-2) pandemic. The greatest threat that is disrupting the normal functioning of society is the exceptionally high species independent transmission. Drug repurposing is understood to be the bes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea065f947773bf8e5c62267b4dd2916
Publikováno v:
Pharmacology & Therapeutics
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has prompted scientists to address an urgent need for defining mechanisms of disease pathology and treatment. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2
Autor:
Azita H, Talasaz, Parham, Sadeghipour, Hessam, Kakavand, Maryam, Aghakouchakzadeh, Elaheh, Kordzadeh-Kermani, Benjamin W, Van Tassell, Azin, Gheymati, Hamid, Ariannejad, Seyed Hossein, Hosseini, Sepehr, Jamalkhani, Michelle, Sholzberg, Manuel, Monreal, David, Jimenez, Gregory, Piazza, Sahil A, Parikh, Ajay J, Kirtane, John W, Eikelboom, Jean M, Connors, Beverley J, Hunt, Stavros V, Konstantinides, Mary, Cushman, Jeffrey I, Weitz, Gregg W, Stone, Harlan M, Krumholz, Gregory Y H, Lip, Samuel Z, Goldhaber, Behnood, Bikdeli
Publikováno v:
Talasaz, A H, Sadeghipour, P, Kakavand, H, Aghakouchakzadeh, M, Kordzadeh-Kermani, E, Van Tassell, B W, Gheymati, A, Ariannejad, H, Hosseini, S H, Jamalkhani, S, Sholzberg, M, Monreal, M, Jimenez, D, Piazza, G, Parikh, S A, Kirtane, A J, Eikelboom, J W, Connors, J M, Hunt, B J, Konstantinides, S V, Cushman, M, Weitz, J I, Stone, G W, Krumholz, H M, Lip, G Y H, Goldhaber, S Z & Bikdeli, B 2021, ' Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 : JACC State-of-the-Art Review ', Journal of the American College of Cardiology, vol. 77, no. 15, pp. 1903-1921 . https://doi.org/10.1016/j.jacc.2021.02.035
Journal of the American College of Cardiology
Journal of the American College of Cardiology
Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9cfd53875c4beb17c4b2acdd6680cbaf
https://vbn.aau.dk/da/publications/4fc75eda-f137-462d-9d70-f4b8fb2a0e43
https://vbn.aau.dk/da/publications/4fc75eda-f137-462d-9d70-f4b8fb2a0e43
Autor:
Bin Deng, Cong Wang, Yu Zhang, Mitchell A. Sullivan, Hanxiang Wang, Chen Shi, Wu Tingting, Jin-Ping Li
Publikováno v:
Carbohydrate Polymers
Highlights • Heparin, used clinically over 80 years, has shown potential for COVID-19 treatment. • The evidence and possible mechanisms of heparin for COVID-19 treatment are discussed. • The prospect of heparin therapy for COVID-19 is presented